Stocks

The table gives an overview of all stocks, alphabetically sorted.
 A-Mark Precious Metals, Inc. AMRK Mar 1, 2021 29.80 +4.78   
 A.H. Belo Corporation (TX) AHC Mar 1, 2021 2.09 +2.45   
 A.O. Smith Corporation AOS Mar 1, 2021 60.67 +2.19   
 A10 Networks, Inc. ATEN Mar 1, 2021 9.64 +3.21   
 AAA - A Rated Corporate Bond Ishares QLTA Mar 1, 2021 56.33 -0.04   
 AAON, Inc. AAON Mar 1, 2021 77.38 +0.36   
 AAR Corp. AIR Mar 1, 2021 42.06 +5.73   
 Aarons Holdings Company, Inc. AAN Mar 1, 2021 22.22 +1.18   
 ABB Ltd ABB Mar 1, 2021 29.28 +1.74   
 Abbott Laboratories ABT Mar 1, 2021 122.21 +2.03   
 AbbVie Inc. ABBV Mar 1, 2021 108.41 +0.62   
 Abcam plc - American Depositary Shares ABCM Mar 1, 2021 22.59 -5.20   
 AbCellera Biologics Inc. - ABCL Mar 1, 2021 39.69 0.00   
 Abeona Therapeutics Inc. ABEO Mar 1, 2021 2.34 -3.31   
 Abercrombie & Fitch Company ANF Mar 1, 2021 27.62 +0.91   
 Aberdeen Asia-Pacific Income Fund Inc FAX Mar 1, 2021 4.34 +0.70   
 Aberdeen Australia Equity Fund Inc IAF Mar 1, 2021 5.63 +1.62   
 Aberdeen Emerging Markets Equity Income Fund, Inc. AEF Mar 1, 2021 8.81 +1.73   
 Aberdeen Global Dynamic Dividend Fund AGD Mar 1, 2021 10.99 +1.85   
 Aberdeen Global Income Fund, Inc. FCO Mar 1, 2021 8.19 +1.36   
 Aberdeen Global Premier Properties Fund AWP Mar 1, 2021 5.58 +1.82   
 Aberdeen Income Credit Strategies Fund ACP Mar 1, 2021 11.16 +0.18   
 Aberdeen Japan Equity Fund, Inc. JEQ Mar 1, 2021 9.19 +1.43   
 Aberdeen Standard Global Infrastructure Income Fund ASGI Mar 1, 2021 19.45 +2.21   
 Aberdeen Total Dynamic Dividend Fund AOD Mar 1, 2021 9.33 +2.30   
 ABIOMED, Inc. ABMD Mar 1, 2021 324.26 -0.09   
 ABM Industries Incorporated ABM Mar 1, 2021 44.03 +1.97   
 Abraxas Petroleum Corporation AXAS Mar 1, 2021 3.93 +1.55   
 Absolute Software Corp ABST Mar 1, 2021 15.60 +2.70   
 AC Immune SA ACIU Mar 1, 2021 7.59 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK